Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Aclaris Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 138
- +5 vs. Q2 2023
- Shares held
- 70.0M
- −1.12M (−1.6%) vs. Q2 2023
- Total value
- $480.0M
- −$257.2M (−34.9%) vs. Q2 2023
- New holders
- 20
- 61 more added
- Sold out
- 15
- 34 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Principal Financial Group Inc | 18,765 | $128.5K | 0.00% | −368−1.9% | Reduced |
| Wells Fargo & Company | 18,287 | $125.3K | 0.00% | −13,880−43.1% | Reduced |
| Belvedere Trading LLC | 15,386 | $105.4K | 0.01% | −172−1.1% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 15,338 | $105.0K | 0.00% | 00.0% | Unchanged |
| Corton Capital Inc. | 14,916 | $102.2K | 0.05% | +14,916 | New |
| CWA Asset Management Group, LLC | 14,705 | $100.7K | 0.01% | +14,705 | New |
| Teacher Retirement System of Texas | 14,088 | $97.0K | 0.00% | +528+3.9% | Added |
| Dynamic Technology Lab Private Ltd | 14,135 | $97.0K | 0.01% | +14,135 | New |
| Arizona State Retirement System | 14,087 | $96.5K | 0.00% | +37+0.3% | Added |
| ProShare Advisors LLC | 13,659 | $93.6K | 0.00% | +53+0.4% | Added |
| Royal Bank of Canada | 13,305 | $92.0K | 0.00% | +7,335+122.9% | Added |
| Vontobel Holding Ltd. | 13,228 | $90.6K | 0.00% | −1,000−7.0% | Reduced |
| Profund Advisors LLC | 13,098 | $89.7K | 0.00% | +13,098 | New |
| Pale Fire Capital SE | 13,000 | $89.0K | 0.01% | +13,000 | New |
| Citigroup Inc | 11,864 | $81.3K | 0.00% | −18,213−60.6% | Reduced |
| J. Goldman & Co LP | 11,456 | $78.5K | 0.00% | −79,483−87.4% | Reduced |
| Point72 Middle East FZE | 10,692 | $73.2K | 0.00% | +10,692 | New |
| Amalgamated Bank | 10,484 | $72.0K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 10,511 | $72.0K | 0.00% | +10,511 | New |
| Ameritas Investment Partners, Inc. | 6,900 | $47.3K | 0.00% | +1,731+33.5% | Added |
| Tower Research Capital LLC (TRC) | 4,264 | $29.2K | 0.00% | +3,056+253.0% | Added |
| Metropolitan Life Insurance Co | 3,901 | $26.7K | 0.00% | +345+9.7% | Added |
| Great West Life Assurance Co | 1,944 | $13.0K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 1,814 | $12.4K | 0.00% | +888+95.9% | Added |
| Nisa Investment Advisors, LLC | 1,067 | $7.31K | 0.00% | −2,182−67.2% | Reduced |
| Northwestern Mutual Wealth Management Co | 500 | $3.42K | 0.00% | 00.0% | Unchanged |
| Quadrant Capital Group LLC | 365 | $2.50K | 0.00% | +312+588.7% | Added |
| Daiwa Securities Group Inc. | 248 | $2.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 284 | $1.95K | 0.00% | +250+735.3% | Added |
| Signaturefd, LLC | 161 | $1.10K | 0.00% | −117−42.1% | Reduced |
| Truvestments Capital LLC | 150 | $1.03K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 96 | $1.00K | 0.00% | −492−83.7% | Reduced |
| AdvisorNet Financial, Inc | 100 | $685 | 0.00% | +100 | New |
| Allworth Financial LP | 38 | $261 | 0.00% | +38 | New |
| Baker Avenue Asset Management, LP | 34 | $233 | 0.00% | +34 | New |
| Advisor Group Holdings, Inc. | 33 | $226 | 0.00% | +17+106.3% | Added |
| Russell Investments Group, Ltd. | 33 | $226 | 0.00% | +33 | New |
| Covestor Ltd | 7 | $0 | 0.00% | −1−12.5% | Reduced |
| Braidwell LP | 0 | $0 | 0.00% | −2,901,194−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −1,485,056−100.0% | Sold out |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −529,839−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −525,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −219,229−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −200,163−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −151,000−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −86,103−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −75,006−100.0% | Sold out |
| Westwood Holdings Group Inc. | 0 | $0 | 0.00% | −51,023−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −40,973−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −30,423−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −912−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −754−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |